MedPath

Ethicon, Inc.

Ethicon, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
1992-01-01
Employees
10K
Market Cap
-
Website
http://www.ethicon.com

The EVICEL® Neurosurgery Phase III Study

Phase 3
Completed
Conditions
Cerebrospinal Fluid Leak
First Posted Date
2015-05-29
Last Posted Date
2019-01-10
Lead Sponsor
Ethicon, Inc.
Target Recruit Count
234
Registration Number
NCT02457546
Locations
🇺🇸

Clinical Investigation Site #27, Los Angeles, California, United States

🇺🇸

Clinical Investigation Site #17, Sacramento, California, United States

🇺🇸

Clinical Investigation Site #18, Jacksonville, Florida, United States

and more 22 locations

The Paediatric EVICEL® Neuro Study

Phase 3
Terminated
Conditions
CSF Leak
First Posted Date
2014-12-05
Last Posted Date
2023-07-14
Lead Sponsor
Ethicon, Inc.
Target Recruit Count
40
Registration Number
NCT02309645
Locations
🇬🇧

Clinical Investigation Site #24, Edinburgh, United Kingdom

🇬🇧

Clinical Investigation Site #22, Leeds, United Kingdom

🇬🇧

Clinical Investigation Site #21, Liverpool, United Kingdom

and more 4 locations

The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study

Phase 3
Completed
Conditions
Soft Tissue Bleeding
Hemorrhage
First Posted Date
2014-08-28
Last Posted Date
2020-08-31
Lead Sponsor
Ethicon, Inc.
Target Recruit Count
40
Registration Number
NCT02227706
Locations
🇧🇪

Clinical Investigation Site #31, Brussels, Belgium

🇨🇦

Clinical Investigation Site #42, Hamilton, Ontario, Canada

🇨🇦

Clinical Investigation Site #40, Toronto, Ontario, Canada

and more 10 locations

The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study

Phase 3
Completed
Conditions
Hemorrhage
Soft Tissue Bleeding
Hepatic Parenchyma Bleeding
First Posted Date
2014-08-28
Last Posted Date
2023-09-08
Lead Sponsor
Ethicon, Inc.
Target Recruit Count
40
Registration Number
NCT02227992
Locations
🇧🇪

Clinical Investigation Site #32, Brussels, Belgium

🇧🇪

Investigative Site #30, Genk, Belgium

🇧🇪

Clinical Investigation Site #31, Gent, Belgium

and more 7 locations

The Bioseal Vascular Study

Phase 4
Completed
Conditions
Vascular Bleeding
Cardiovascular Bleeding
Hemorrhage
First Posted Date
2014-03-24
Last Posted Date
2018-03-08
Lead Sponsor
Ethicon, Inc.
Target Recruit Count
252
Registration Number
NCT02094885
Locations
🇨🇳

Clinical Investigation Site #21, Guangzhou City, Guangdong, China

🇨🇳

Clinical Investigation Site #32, Nanjing, Jiangsu, China

🇨🇳

Clinical Investigation Site #31, Nanjing, Jiangsu, China

and more 6 locations

The Fibrin Pad CV Phase III Study

Phase 3
Completed
Conditions
Cardiovascular Disease
First Posted Date
2014-01-20
Last Posted Date
2017-08-15
Lead Sponsor
Ethicon, Inc.
Target Recruit Count
156
Registration Number
NCT02040428
Locations
🇺🇸

Clinical Investigation Site #15, Atlanta, Georgia, United States

🇺🇸

Clinical Investigation Site #14, Indianapolis, Indiana, United States

🇺🇸

Clinical Investigation Site #16, Baltimore, Maryland, United States

and more 21 locations

Phase IV Bioseal Study in Brain Tumor Surgery

Phase 4
Completed
Conditions
Hemostasis
Meningioma Surgery
First Posted Date
2014-01-14
Last Posted Date
2018-02-26
Lead Sponsor
Ethicon, Inc.
Target Recruit Count
256
Registration Number
NCT02034799
Locations
🇨🇳

Clinical Investigation Site #6, Zhengzhou, Henan, China

🇨🇳

Clinical Investigation Site #5, Changsha, Hunan, China

🇨🇳

Clinical Investigation Site #3, Chengdu, Sichuan, China

and more 4 locations

The EVARREST® Fibrin Sealant Patch Liver Study

Phase 3
Completed
Conditions
Hemorrhage
First Posted Date
2013-11-25
Last Posted Date
2016-07-11
Lead Sponsor
Ethicon, Inc.
Target Recruit Count
102
Registration Number
NCT01993888
Locations
🇺🇸

Clinical Investigation Site #13, Birmingham, Alabama, United States

🇺🇸

Clinical Investigation Site #10, Augusta, Georgia, United States

🇺🇸

Clinical Investigation Site #16, Chicago, Illinois, United States

and more 14 locations

EVARREST™ Fibrin Sealant Patch Post-Market Study

Phase 4
Completed
Conditions
Hemorrhage
Soft Tissue Bleeding
First Posted Date
2013-07-18
Last Posted Date
2018-01-17
Lead Sponsor
Ethicon, Inc.
Target Recruit Count
150
Registration Number
NCT01902459
Locations
🇺🇸

Clinical Site #10, Saint Louis, Missouri, United States

Occipital Nerve Stimulation in the Treatment of Migraine

Phase 1
Terminated
Conditions
Migraine
First Posted Date
2013-05-16
Last Posted Date
2013-07-17
Lead Sponsor
Ethicon, Inc.
Target Recruit Count
1
Registration Number
NCT01855672
Locations
🇺🇸

ActivMed, Newington, New Hampshire, United States

🇺🇸

Clinilabs, New York, New York, United States

🇺🇸

Community Research, Cincinnati, Ohio, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath